Autoantibody-mediated central nervous system channelopathies

Area of Science:

• Neuroscience
• Immunology
• Neurology

Background:

• Autoimmune channelopathies are a rapidly advancing field in neurology.
• Autoantibodies targeting neuronal and glial channels are key in conditions like neuromyelitis optica and autoimmune encephalitis.
• The discovery of these autoantibodies has transformed neurologic practice.

Purpose of the Study:

• To review the neuroscience and immunologic basis of autoimmune channelopathies.
• To discuss the molecular effects, clinical phenotypes, and treatment of these disorders.
• To highlight progress and future directions in the field.

Main Methods:

• Review of scientific literature on autoimmune channelopathies.
• Analysis of autoantibody specificities and their targets.
• Discussion of clinical presentations and therapeutic strategies.

Main Results:

• Tens of surface antibody specificities targeting CNS channels have been identified.
• Pathogenic autoantibodies targeting extracellular epitopes are central to these disorders.
• Early diagnosis and immunotherapy improve outcomes for most patients.

Conclusions:

• Autoimmune channelopathies are increasingly recognized and treatable with immunotherapy.
• Further research is needed to address unmet medical needs and improve clinical recognition.
• Understanding autoantibody mechanisms offers diagnostic and therapeutic opportunities.